How a mutant worm's reaction to a foul smell could lead to new disease treatment avenues

November 10, 2015

BUFFALO, N.Y. -- Several years ago, University at Buffalo biologists noticed something odd.

They were studying how a worm called C. elegans would react when different genes were deleted from its DNA. One particularly interesting deletion resulted in nematodes with a heightened sense of smell: They backed away from repulsive odors unusually fast.

The lead researchers, Denise Ferkey and Michael Yu, took note; they had seen this behavior before.

In prior, unrelated experiments, the same species of worm had become hypersensitive to smell when its nerve cells experienced problems with dopamine signaling, a cellular process that helps control how readily cells can communicate with one another.

The researchers wondered: Was a similar issue at play again?

That question -- and that curiosity -- led the scientists on a multi-year research project that could one day open new treatment avenues for diseases ranging from schizophrenia to Parkinson's.

Missing gene alters dopamine signaling

On Nov. 10 in the journal Science Signaling, Ferkey and Yu's team will report that the mutant worms they were studying had altered dopamine signaling because the animals were missing the gene for an enzyme called PRMT-5, which facilitates another important cellular process -- protein arginine methylation.

When researchers took the gene away, the worms stopped making PRMT-5; protein arginine methylation decreased; and dopamine signaling declined as a result. The scientists also discovered that the same mechanism -- arginine methylation -- regulates dopamine signaling in human cells.

"We're excited about this finding because dopamine signaling is involved in such a diversity of biological processes," says Ferkey, PhD, an associate professor of biological sciences in the UB College of Arts and Sciences. "We also know that it's linked to Parkinson's disease, schizophrenia and drug addiction. Our research opens up possibilities for a whole new class of drugs."

"One of the interesting things we saw in our study was that dopamine signaling became weaker, but it didn't turn it off completely," says Yu, PhD, UB associate professor of biological sciences. "A lot of treatments take an all-or-nothing approach: You either have something or you don't. But with arginine methylation, we may be able to take a softer approach and fine-tune how powerful the signaling is."

"From the standpoint of pharmaceuticals, modulation is good because it could reduce side effects," Ferkey adds. "The body may respond better to fine-tuning than to a sledgehammer."

A versatile avenue for therapeutics

Dopamine is a neurotransmitter -- a chemical that plays an important role in how nerve cells respond to stimuli and communicate with one another.

Produced naturally in the brain, dopamine has become a neuroscience rock star: It's involved in how the mind registers rewards, and media have reported on the chemical's connection to addiction, gambling and pleasure. Dopamine is also involved in many other biological processes, including an array of diseases.

One way dopamine influences intercellular communication is by binding to receptors found in nerve cells, an action that can influence how likely these cells are to 'fire' and communicate messages to other cells.

Ferkey and Yu's team traced how the PRMT-5 enzyme affects this process. In doing so, they show how versatile their discovery could be in pursuing treatments for diverse diseases.

PRMT stands for 'protein arginine methyltransferase,' and PRMT enzymes facilitate the chemical process of arginine methylation, the fastening of a methyl group (made from one carbon and three hydrogen atoms) to proteins inside cells.

Arginine methylation is crucial to many bodily functions, but until now, scientists did not know it mattered in dopamine signaling, said Yu, whose research focuses on PRMTs.

His and Ferkey's new study found that PRMT-5 helps a methyl molecule attach to dopamine receptors called D2-like receptors in nerve cells. With the methyl group attached, the receptors emit stronger signals, responding more powerfully when dopamine molecules latch on.

This influences the sensitivity of the nerve cells, changing how likely they are to communicate important messages to other cells.

This held true in both worm cells and human cells, which shows that the role of PRMTs in dopamine signaling has been conserved through evolution -- a quality that often points to a particularly useful adaptation.

The dopamine receptors the researchers studied belong to a family called G protein-coupled receptors (GPCRs), and the newly discovered PRMT-5 mechanism may be active on hundreds of these receptors -- creating huge potential for new therapeutics.

A win for basic science

A side effect of losing PRMT-5 in C. elegans is a heightened sense of smell: In the worms, dopamine signaling acts as a brake or check on the sensory system's response to odorants. So when you remove PRMT-5 and diminish dopamine signaling, the brake comes off and the mutant worms react more strongly to odor, Ferkey says.

"Our study is a big win for basic science research," she says. "We didn't set out to identify a new means of regulating dopamine signaling. We saw this very curious phenotype -- this mutant worm with this heightened sense of smell -- and remembered it from previous experiments dealing with something totally different."

"Many of science's great findings are serendipitous," Yu adds. "Our story shows why it's so important for society to support basic science research."

University at Buffalo

Related Dopamine Articles from Brightsurf:

Dopamine surge reveals how even for mice, 'there's no place like home'
''There's no place like home,'' has its roots deep in the brain.

New dopamine sensors could help unlock the mysteries of brain chemistry
In 2018, Tian Lab at UC Davis Health developed dLight1, a single fluorescent protein-based biosensor.

Highly sensitive dopamine detector uses 2D materials
A supersensitive dopamine detector can help in the early diagnosis of several disorders that result in too much or too little dopamine, according to a group led by Penn State and including Rensselaer Polytechnic Institute and universities in China and Japan.

Dopamine neurons mull over your options
Researchers at the University of Tsukuba have found that dopamine neurons in the brain can represent the decision-making process when making economic choices.

Viewing dopamine receptors in their native habitat
A new study led by UT Southwestern researchers reveals the structure of the active form of one type of dopamine receptor, known as D2, embedded in a phospholipid membrane.

Significant differences exist among neurons expressing dopamine receptors
An international collaboration, which included the involvement of the research team from the Institut de Neurociències of the UAB (INC-UAB), has shown that neurons expressing dopamine D2 receptors have different molecular features and functions, depending on their anatomical localization within the striatum.

How dopamine drives brain activity
Using a specialized magnetic resonance imaging (MRI) sensor that can track dopamine levels, MIT neuroscientists have discovered how dopamine released deep within the brain influences distant brain regions.

Novelty speeds up learning thanks to dopamine activation
Brain scientists led by Sebastian Haesler (NERF, empowered by IMEC, KU Leuven and VIB) have identified a causal mechanism of how novel stimuli promote learning.

Evidence in mice that childhood asthma is influenced by the neurotransmitter dopamine
Neurons that produce the neurotransmitter dopamine communicate with T cells to enhance allergic inflammation in the lungs of young mice but not older mice, researchers report Nov.

Chronic adversity dampens dopamine production
People exposed to a lifetime of psychosocial adversity may have an impaired ability to produce the dopamine levels needed for coping with acutely stressful situations.

Read More: Dopamine News and Dopamine Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to